Cabergoline and Cialis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cabergoline (cabergoline) and Cialis (tadalafil). Common drug interactions include depression among males.

The phase IV clinical study analyzes what interactions people have when they take Cabergoline and Cialis. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 6,257 Cabergoline users. Check the latest studies of Cabergoline.

What is Cialis?

Cialis has active ingredients of tadalafil. It is often used in erection problems. eHealthMe is studying from 28,532 Cialis users. Check the latest studies of Cialis.



On Jul, 17, 2026

18 people who take Cabergoline and Cialis together, and have interactions are studied.

Cabergoline and Cialis drug interactions.

What are the common drug interactions of Cabergoline and Cialis, by gender? *:

female:

n/a

male:

  1. Depression
  2. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  3. Back disorder
  4. Back pain
  5. Bleeding time prolonged
  6. Decreased activity
  7. Dizziness
  8. Drug ineffective
  9. Drug intolerance (drug sensitivity)
  10. Dystonia (abnormal muscle tone)

What are the common drug interactions of Cabergoline and Cialis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Aggression
  2. Hypersexuality
  3. Libido increased (increased sexual urge to have sex)
  4. Masked facies (mask like facial expression, display little facial expression)
  5. Pathological gambling
  6. Psychomotor skills impaired
  7. Tremor (trembling or shaking movements in one or more parts of your body)

40-49:

n/a

50-59:

  1. Depression
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Emotional distress
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Pain
  7. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  8. Decreased activity
  9. Dystonia (abnormal muscle tone)
  10. Oedema (fluid collection in tissue)

60+:

  1. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  2. Arthralgia (joint pain)
  3. Nausea (feeling of having an urge to vomit)
  4. Neuropathy peripheral (surface nerve damage)
  5. Pain in extremity
  6. Death
  7. Drug ineffective
  8. Eyelid ptosis (falling of the upper or lower eyelid)
  9. Hyperkalaemia (damage to or disease of the kidney)
  10. Loss of libido (loss of sexual urge)

What are the existing conditions these people have? *

  1. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 3 people, 16.67%
  2. Hiv Infection: 3 people, 16.67%
  3. Parkinson's Disease: 3 people, 16.67%
  4. Indigestion: 2 people, 11.11%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.11%
  6. Pain: 2 people, 11.11%
  7. Hypersensitivity: 2 people, 11.11%
  8. Nasal Disorder (diseases of nose): 2 people, 11.11%
  9. Migraine (headache): 2 people, 11.11%
  10. Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Cabergoline and Cialis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cabergoline and Cialis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cabergoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cialis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cabergoline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cialis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cabergoline and tadalafil (the active ingredients of Cabergoline and Cialis, respectively), and Cabergoline and Cialis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: